Lastentautien vastuualue

Julkaisut 2011
Publications 2011

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.

1 Alhonen S et al. Extended family history of diabetes and autoimmune diseases in children with and without type 1 diabetes.
2 Arkkola T et al. Relationship of maternal weight status and weight gain rate during pregnancy to the development of advanced beta cell autoimmunity in the offspring: a prospective birth cohort study.
3 Baets J et al. Genetic spectrum of hereditary neuropathies with onset in the first year of life.
4 Black S et al. Hemagglutination inhibition antibody titers as a correlate of protection for inactivated influenza vaccines in children.
5 Blazevic V et al. Norovirus VLPs and rotavirus VP6 protein as combined vaccine for childhood gastroenteritis.
6 Brown CT et al. Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes.
7 Caja S et al. Antibodies in celiac disease: implications beyond diagnostics.
8 Collin P et al. Keliakia.
9 de PEE S et al. The devil is in the details.
10 Della CIOPPA G et al. Trivalent and quadrivalent MF59(®)-adjuvanted influenza vaccine in young children: a dose- and schedule-finding study.
11 Dennehy PH et al. Efficacy of the pentavalent rotavirus vaccine, RotaTeq® (RV5), between doses of a 3-dose series and with less than 3 doses (incomplete regimen).
12 Don M, Korppi M. Serologically defined human metapneumovirus in pediatric community-acquired pneumonia.
13 Don M et al. Don'T forget serum in the diagnosis of human bocavirus infection.
14 Einarsdottir E et al. Multiple independent variants in 6q21-22 associated with susceptibility to celiac disease in the Dutch, Finnish and Hungarian populations.
15 Einarsdottir E et al. Genome-wide analysis of extended pedigrees confirms IL2-IL21 linkage and shows additional regions of interest potentially influencing coeliac disease risk.
16 Elding Larsson H et al. Reduced prevalence of diabetic ketoacidosis at diagnosis of type 1 diabetes in young children participating in longitudinal follow-up.
17 Erkkola M et al. Nutrient intake variability and number of days needed to assess intake in preschool children.
18 Forbes JM et al. Receptor for advanced glycation end-products (RAGE) provides a link between genetic susceptibility and environmental factors in type 1 diabetes.
19 Frandsen TL et al. Individualized toxicity-titrated 6-mercaptopurine increments during high-dose methotrexate consolidation treatment of lower risk childhood acute lymphoblastic leukaemia. A Nordic Society of Paediatric Haematology and Oncology (NOPHO) pilot study.
20 Gandhi M et al. Height gain during early childhood is an important predictor of schooling and mathematics ability outcomes.
21 Giongo A et al. Toward defining the autoimmune microbiome for type 1 diabetes.
22 Götz A et al. Exome sequencing identifies mitochondrial alanyl-tRNA synthetase mutations in infantile mitochondrial cardiomyopathy.
23 Hagopian WA et al. The Environmental Determinants of Diabetes in the Young (TEDDY): genetic criteria and international diabetes risk screening of 421 000 infants.
24 Hakkarainen E et al. Visual attention study in youth with spastic cerebral palsy using the event-related potential method.
25 Hekkala A et al. Family history of diabetes and distribution of class II HLA genotypes in children with newly diagnosed type 1 diabetes: effect on diabetic ketoacidosis.
26 Helmiö P et al. Towards better patient safety: WHO Surgical Safety Checklist in otorhinolaryngology.
27 Hiltunen P. Pikkupojan pitkittynyt ripuli.
28 Hublin C et al. Narkolepsiapotilaan toimintakyvyn ja haitta-asteen arviointi.
29 Huhti L et al. Norovirus GII-4 causes a more severe gastroenteritis than other noroviruses in young children.
30 Hyvärinen M, Korppi M. Viral bronchiolitis and asthma development: Lessons from longitudinal studies.
31 Hyvärinen M et al. Outcome after bronchiolitis depends on disease definition.
32 Jahnukainen T et al. Clinical outcome and occurrence of uveitis in children with idiopathic tubulointerstitial nephritis.
33 Jahnukainen T et al. Eye examination is important in patients with tubulointerstitial nephritis.
34 Jartti T, Korppi M. Rhinovirus-induced bronchiolitis and asthma development.
35 Jauhola O et al. Cyclosporine A vs. methylprednisolone for Henoch-Schönlein nephritis: a randomized trial.
36 Juhola J et al. Tracking of serum lipid levels, blood pressure, and body mass index from childhood to adulthood: the Cardiovascular Risk in Young Finns Study.
37 Kalavainen M et al. Long-term efficacy of group-based treatment for childhood obesity compared with routinely given individual counselling.
38 Kallio J. Systems biological study of drosophila immune signaling.
39 Kallio P et al. Parent-reported food allergy requiring an avoidance diet in children starting elementary school.
40 Kivistö JE et al. Adolescent risk factors for poisonings - a prospective cohort study.
41 Knip M. Pathogenesis of type 1 diabetes: implications for incidence trends.
42 Knip M et al. Early feeding and risk of type 1 diabetes: experiences from the Trial to Reduce Insulin-dependent diabetes mellitus in the Genetically at Risk (TRIGR).
43 Koivistoinen T et al. Metabolic syndrome in childhood and increased arterial stiffness in adulthood - The Cardiovascular Risk in Young Finns Study.
44 Koivistoinen T et al. Apolipoprotein B is related to arterial pulse wave velocity in young adults: the Cardiovascular Risk in Young Finns Study.
45 Korpimäki S et al. Gluten-sensitive hypertransaminasemia in celiac disease: an infrequent and often subclinical finding.
46 Korppi M. Non-specific diagnosis of bacterial pneumonia in children.
47 Korppi M. Early wheeze reduces lung function: or is it viral infection.
48 Korppi M. How to diagnose Mycoplasma pneumoniae etiology in a child with pneumonia.
49 Korppi M et al. Värekarvojen synnynnäiset toimintahäiriöt lapsilla.
50 Korppi M et al. Hyperimmunoglobulinemia D and periodic fever syndrome in children. Review on therapy with biological drugs and case report.
51 Koskenkorva P et al. Severer phenotype in Unverricht-Lundborg disease (EPM1) patients compound heterozygous for the dodecamer repeat expansion and the c.202C>T mutation in the CSTB gene.
52 Kuchinskaya E et al. Interphase fluorescent in situ hybridization deletion analysis of the 9p21 region and prognosis in childhood acute lymphoblastic leukaemia (ALL): results from a prospective analysis of 519 Nordic patients treated according to the NOPHO-ALL 2000 protocol.
53 Kurppa K et al. Spontaneous negative seroconversion of endomysial antibodies does not exclude subsequent celiac disease.
54 Kurppa K et al. Celiac disease and health-related quality of life.
55 Kurppa K et al. Antibodies Against Deamidated Gliadin Peptides in Early-stage Celiac Disease.
56 Kuusisto KM et al. Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.
57 Lahdes-vasama TT et al. Urodynamic assessment of children treated with botulinum toxin A injections for urge incontinence: a pilot study.
58 Lahdes-Vasama TT et al. Preoperative embolization of giant sacrococcygeal teratoma in a premature newborn.
59 Lee AW et al. Immunogenicity and safety of a Haemophilus influenzae B (Hib)-hepatitis B vaccine with a modified process hepatitis B component administered with concomitant pneumococcal conjugate vaccine to infants.
60 Lehtinen P et al. Incidence trends of pediatric inflammatory bowel disease in Finland, 1987-2003, a nationwide study.
61 Lindfors K et al. An update on the diagnostics of celiac disease.
62 Lindfors K et al. Serodiagnostic assays for celiac disease based on the open or closed conformation of the autoantigen, transglutaminase 2.
63 Lindfors K et al. IgA-class autoantibodies against neuronal transglutaminase, TG6 in celiac disease: No evidence for gluten dependency.
64 Lindfors K et al. Galactosylation of serum IgA1 o-glycans in celiac disease.
65 Lohi O, Vettenranta K. Lasten pienentyneet valkosolumäärät.
66 Lumia M et al. Dietary fatty acid composition during pregnancy and the risk of asthma in the offspring.
67 Lähdeaho M-L et al. Lasten kotisairaala.
68 Lähdeaho ML et al. Small- bowel mucosal changes and antibody responses after low- and moderate-dose gluten challenge in celiac disease.
69 Lönnerholm G et al. In vitro cellular drug resistance adds prognostic information to other known risk-factors in childhood acute lymphoblastic leukemia.
70 Maijala H et al. Äkillisesti sairastuneen lapsen perheen ja hoitohenkilökunnan näkemyksiä saadusta ja annetusta hoidosta.
71 Mecklin M et al. Emergency treatment of obstructive bronchitis: change from nebulizers to metered dose inhalers with spacers.
72 Mustila T et al. Pediatric Cushing´s disease due to pituitary hyperplasia.
73 Mäkelä E et al. Magnetic resonance imaging of acute scrotum.
74 Nadalutti C et al. Extracellular transglutaminase 2 has a role in cell adhesion, whereas intracellular transglutaminase 2 is involved in regulation of endothelial cell proliferation and apoptosis.
75 Niemi E, Korppi M. Parapneumonic empyema in children before the era of pneumococcal vaccination.
76 Nurminen K et al. Prevalence of norovirus GII-4 antibodies in Finnish children.
77 Nwaru BI et al. Maternal diet during lactation and allergic sensitization in the offspring at age of 5.
78 Nwaru BI et al. Intake of antioxidants during pregnancy and the risk of allergies and asthma in the offspring.
79 Nwaru BI et al. Validation of the Finnish ISAAC questionnaire on asthma against anti-asthmatic medication reimbursement database in 5-year-old children.
80 Oikarinen S et al. Enterovirus RNA in blood is linked to the development of type 1 diabetes.
81 Oja SS, Saransaari P. Release of endogenous amino acids from the striatum from developing and adult mice in ischemia.
82 Olkinuora H et al. The impact of early viral infections and graft-versus-host disease on immune reconstitution following paediatric stem cell transplantation.
83 Outinen TK et al. High activity of indoleamine 2,3-dioxygenase is associated with renal insufficiency in Puumala hantavirus induced nephropathia epidemica.
84 Paassilta M, Korppi M. Lasten antibioottiallergia.
85 Paassilta M et al. Acute bronchial obstruction in preschool children: Change from nebulizers to metered dose inhalers with spacers.
86 Phuka J et al. Acceptability of three novel lipid-based nutrient supplements among Malawian infants and their caregivers.
87 Pirilä S et al. Executive functions in youth with spastic cerebral palsy.
88 Pohjankoski H et al. First-year purchases of disease-modifying drugs of incident patients with chronic juvenile arthritis in Finland.
89 Poutanen T, Eerola A. Sydänlapsen liikuntaa ei yleensä tarvitse rajoittaa.
90 Prasad M et al. Are serum a- and ß-carotene concentrations associated with the development of advanced beta-cell autoimmunity in children with increased genetic susceptibility to type 1 diabetes?
91 Puustinen L et al. Norovirus genotypes in endemic acute gastroenteritis of infants and children in Finland between 1994 and 2007.
92 Puustinen L et al. Noroviruses as a major cause of acute gastroenteritis in children in Finland, 2009-2010.
93 Pyrhönen K. Food allergies and hypersensitivities among children in South Karelia.
94 Pyrhönen K et al. Heredity of food allergies in an unselected child population: an epidemiological survey from Finland.
95 Pyrhönen K et al. Real-life epidemiology of food allergy testing in Finnish children.
96 Pyrhönen K et al. SKARP--A population-based cohort study of childhood food-associated symptoms perceived by parents and food allergies diagnosed by physicians: design, methods and participation.
97 Rantanen K et al. Cognitive impairment in preschool children with epilepsy.
98 Rauhavirta T et al. Epithelial transport and deamidation of gliadin peptides: a role for coeliac disease patient immunoglobulin A.
99 Remes ST et al. Association of serum-soluble CD26 and CD30 levels with asthma, lung function and bronchial hyper-responsiveness at school age.
100 Renko M et al. Lääketieteen opiskelijoiden tiedonhaku- ja lukutottumukset.
101 Rozenbaum MH et al. Cost-effectiveness of rotavirus vaccination in the Netherlands; the results of a consensus model.
102 Ruuhilehto K et al. HaiPro - millaisista vaaratapahtumista terveydenhuollon yksiköissä opittiin vuosina 2007-2009?
103 Ruuskanen A et al. Persistently positive gliadin antibodies without transglutaminase antibodies in the elderly: gluten intolerance beyond coeliac disease.
104 Ryhänen SJ et al. Impact of intranasal insulin on insulin antibody affinity and isotypes in young children with HLA-conferred susceptibility to type 1 diabetes.
105 Rämet M et al. Pattern recognition receptors and genetic risk for rsv infection: value for clinical decision-making?
106 Rämet M, Meri S. Vuoden 2011 lääketieteen Nobelin palkinto immunologeille.
107 Räsänen S et al. Rotavirus gastroenteritis in Finnish children in 2006-2008, at the introduction of rotavirus vaccination.
108 Räsänen S et al. Noroviruses in children seen in a hospital for acute gastroenteritis in Finland.
109 Salo E et al. Lasten atyyppiset mykobakteeri-infektiot lisääntyvät.
110 Sartoneva R et al. Comparison of a poly-L-lactide-co-e-caprolactone and human amniotic membrane for urothelium tissue engineering applications.
111 Seppälä E et al. Viral interference induced by live attenuated virus vaccine (OPV) can prevent otitis media.
112 Sidoroff V et al. Lung function and overweight in school aged children after early childhood wheezing.
113 Siljander H, Knip M. Autovasta-aineet tyypin 1 diabeteksessa.
114 Siren A. Childhood absence epilepsy. An epidemiological, neuropsychological and molecular genetic study.
115 Solakivi T et al. Serum fatty acid profile in subjects with irritable bowel syndrome.
116 Stenman S. Coeliac disease-inducing glutein.
117 Sysi-aho M et al. Metabolic regulation in progression to autoimmune diabetes.
118 Sätilä H et al. Mitä annettavaa botuliinilla on lapsille?
119 Takala RS et al. A pilot study of the implementation of WHO Surgical Checklist in Finland: improvements in activities and communication.
120 Tammela O. Tavoitteena onnistunut imetys.
121 Trigr Study Group et al. The Trial to Reduce IDDM in the Genetically at Risk (TRIGR) study: recruitment, intervention and follow-up.
122 Tuokkala J et al. Välttämisruokavalio ruoka-allergiassa - pitääkö olla tarkkana vai kannattako lepsuilla?
123 Tynjälä P et al. Aggressive Combination Drug Therapy in Very Early Polyarticular Juvenile Idiopathic Arthritis (ACUTE-JIA): a multicentre randomised open-label clinical trial.
124 Ukkola A et al. Diet improves perception of health and well-being in symptomatic, but not asymptomatic, patients with celiac disease.
125 Ulvila J et al. Drosophila phagocytosis - still many unknowns under the surface.
126 Valanne S, Rämet M. Banaanikärpänen - geneettisesti verraton mallieläin tutkimukseen.
127 Valanne S et al. The Drosophila Toll signaling pathway.
128 Valve K et al. Tuberkuloosiepidemian selvittäminen.
129 van DER Meere J et al. Interference control in children with first episode major depression: a brief report.
130 Vesikari T et al. Tetravalent meningococcal serogroups A, C, W-135 and Y conjugate vaccine is well tolerated and immunogenic when co-administered with measles-mumps-rubella-varicella vaccine during the second year of life: An open, randomized controlled trial.
131 Vesikari T et al. Results from a randomized clinical trial of coadministration of RotaTeq, a pentavalent rotavirus vaccine, and NeisVac-C, a meningococcal serogroup C conjugate vaccine.
132 Vesikari T et al. Immunogenicity, reactogenicity and safety of the human rotavirus vaccine RIX4414 oral suspension (liquid formulation) in Finnish infants.
133 Vesikari T et al. Immunogenicity of 10-valent pneumococcal nontypeable Haemophilus Influenzae Protein D Conjugate Vaccine when administered as catch-up vaccination to children 7 months to 5 years of age.
134 Vesikari T et al. Oil-in-water emulsion adjuvant with influenza vaccine in young children.
135 Vesikari T et al. Safety and immunogenicity of a modified process hepatitis B vaccine in healthy infants.
136 Vilppula A et al. Clinical benefit of glutein-free diet in screen-detected older celiac disease patients.
137 Virtanen SM et al. Feasibility and compliance in a nutritional primary prevention trial in infants at increased risk for type 1 diabetes.
138 Virtanen SM et al. Food consumption and advanced ß cell autoimmunity in young children with HLA-conferred susceptibility to type 1 diabetes: a nested case-control design.
139 Virtanen SM et al. Early introduction of root vegetables in infancy associated with advanced ß-cell autoimmunity in young children with human leukocyte antigen-conferred susceptibility to Type 1 diabetes.
140 Virtanen SM et al. Maternal food consumption during pregnancy and risk of advanced ß-cell autoimmunity in the offspring.
141 Visakorpi T et al. Kliininen tutkimus Suomessa:tutkimuksen rakenteet.
142 Vuohelainen T et al. Decreased free water clearance is associated with worse respiratory outcomes in premature infants.
143 Vuorela N et al. Change in prevalence of overweight and obesity in Finnish children - comparison between 1974 and 2001.
144 Vuorela N et al. Toddlers get slimmer while adolescents get fatter - BMI distribution in five birth cohorts from four decades in Finland.
145 Xie T et al. Structure of the 30-kDa Sin3-associated Protein (SAP30) in Complex with the Mammalian Sin3A Corepressor and Its Role in Nucleic Acid Binding.
146 Åkerblom HK et al. The trial to reduse IDDM in the genetically at risk (TRIGR) study: recruitment, intervention an follow-up.
Julkaisutietokanta 21.9.2012 Publications Data Base 21.9.2012